Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Urinary System Drugs
- Endocrine System
- Other
Pharmaceutical
- Pharmaceutical intermediates
- Heterocyclic Compound
- OLED material intermediate
- Diphenylamine intermediates
- Nutritional Supplements
- Pharmaceutical raw materials
Medicine Excipients
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Pharmaceutical Edoxaban (Tosylate Monohydrate) Raw Materials Powder CAS 1229194-11-9 API Factory Sup
Product Overview:
Edoxaban Powder is sold under the trade name Savaysa.Edoxaban (Tosylate Monohydrate) is a selective coagulation factor Xa inhibitor oral tablet.Edoxaban (Tosylate Monohydrate) Powder is used in the prophylactic treatment of deep vein thrombosis (DVT) and pulmonary embolism to reduce the risk of stroke and systemic embolic events in patients with non-valvular atrial fibrillation (NVAF). Valvular Atrial Fibrillation (NVAF) patients at risk for stroke and systemic embolic events and is currently available in 60mg, 30mg and 15mg sizes.
Pharmaceutical Edoxaban (Tosylate Monohydrate) Raw Materials Powder CAS 1229194-11-9 API Factory Sup Attributes
CAS:1229194-11-9
MF: C31H38ClN7O7S2
MW: 720.26
EINECS: 1592732-453-0
Specification: 99% min Edoxaban (Tosylate Monohydrate)
Sample: Dopamine Hydrochloride
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance: White Powder
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
Pharmaceutical Edoxaban (Tosylate Monohydrate) Raw Materials Powder CAS 1229194-11-9 API Factory Sup Details
Edoxaban (Tosylate Monohydrate) Powder Usage and Synthesis.
Edoxaban Powder is sold under the trade name Savaysa.Edoxaban (Tosylate Monohydrate) is a selective coagulation factor Xa inhibitor oral tablet.
Edoxaban (Tosylate Monohydrate) Powder is used in the prophylactic treatment of deep vein thrombosis (DVT) and pulmonary embolism to reduce the risk of stroke and systemic embolic events in patients with non-valvular atrial fibrillation (NVAF).
Valvular Atrial Fibrillation (NVAF) patients at risk for stroke and systemic embolic events and is currently available in 60mg, 30mg and 15mg sizes.
Uses and functions of Edoxaban (Tosylate Monohydrate) Powder.
Pharmacological Effects of Edoxaban (Tosylate Monohydrate) Powder.
Production method of Edoxaban (Tosylate Monohydrate) Powder.
